European Archives - Page 967 of 1424 - European Medical Journal

Immunity to Respiratory Viruses by Targeting Killer T Cells

Immunity to Respiratory Viruses by Targeting Killer T Cells

COVID-19 has been shown to significantly affect the lungs. To understand how the immune cells of the lung respond to viral infection, researchers…

EMJ Nephrology 8 [Supplement 2] 2020

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a disease process characterised by necrosis and inflammatory damage to the…

Complement and Neutrophils in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis – Partners in Crime: Interviews with Two Key Opinion Leaders

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises a group of rare, necrotising inflammatory diseases.

Talking to Olli Rundgren

Olli Rundgren, CEO, Psyon Games, chats about the power of games and how they can positively impact health and behaviour. Olli discusses the formation of habits, the opportunity for education and data collection, and Psyon Games’ WHO endorsed game ‘Antidote’.

Convalescent Plasma Transfusion Therapy for COVID-19 Shows Promise

CONVALESCENT plasma transfusion for the treatment of severe COVID-19 is currently being trialled in the UK

Will Selective CAR T Cells for Acute Myeloid Leukaemia Replace Chemotherapy?

IMMUNOTHERAPY for acute myeloid leukaemia (AML) has shown promise in recent years, and now results from a study that demonstrated improved selectivity

Safety and Efficacy of Mavacamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: The MAVERICK-HCM Study

Hypertrophic cardiomyopathy (HCM) is a progressive primary myocardial disorder characterised by unexplained left ventricular…

Successful Outcome of Cardiac Arrest Management in a Morbidly Obese Parturient Woman During Caesarean Section Delivery: A Case Report

Compression of the inferior vena cava and abdominal aorta by the gravid uterus in addition to hypotension following spinal anaesthesia during…

EMJ Cardiology 8 Suppl 1

EMJ Cardiology 8 [Supplement 1] 2020

The poster review article entitled “Safety and Efficacy of Mavacamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy…

Talking to Sarah Rickwood

Sarah Rickwood, Vice President of Thought Leadership and Marketing, IQVIA, talks about the key trends and challenges that have shaped the past decade in pharma, RWE, multi-channel marketing and the future of drug launch post-COVID-19.